vutrisiran ATTR Amvuttra

Selected indexed studies

• Vutrisiran: First Approval. (Drugs, 2022) [PMID:35997942]
• Vutrisiran: A Review in Polyneuropathy of Hereditary Transthyretin-Mediated Amyloidosis. (Drugs, 2023) [PMID:37728865]
• A mutation in transthyretin gene in a Mexican patient leading to hereditary amyloidosis: a case report. (J Med Case Rep, 2025) [PMID:40760461]

_Worker-drafted node — pending editorial review._